In June 2017, DART Imaging was founded in Haidian Pioneer Park in Beijing, China. The founder, Dr. Tao Wu, is one of early inventors and researchers of DBT. His work on DBT won the American Association of Physics in Medicine (AAPM) Young Investigator Award in 2003, and the Sylvia Sorkin Greenfield Award for the Best Paper published in Medical Physics in 2004. Dr. Wu has developed the world's first DBT prototype and reconstruction algorithm in Massachusetts General Hospital (MGH). In 2015, the first DBT system was collected by the Russel Museum of Medical History and Innovation in Boston. He has also made pioneering contributions to the development and clinical benefits of DBT. In 2005, Dr. Wu started working on the commercialization of DBT technology, leading to the first FDA-approved DBT product in 2011. Dr. Wu has been serving the Tomosynthesis and Mammography committees of the AAPM. He has participated in the development of national standards for quality control for digital mammography and DBT in China.
DART Imaging focuses on early detection of breast cancer, reducing the cancer mortality and improving the quality of life.
Company Mission:
Follow evidence-based medicine, develop and promote new technologies for breast cancer screening and diagnosis.
